Zoledronic Acid Plus Chemotherapy Reduces Risk Of Breast Cancer Recurrence In Post-Me

[News]

Post-menopausal breast cancer patients who receive zoledronic acid in addition to chemotherapy have a significantly lower risk of cancer recurrence, researchers from Weston Park Hospital, Sheffield, England, reported at the European Multidisciplinary Cancer Congress 2011, Stockholm, Sweden...

More... (http://www.medicalnewstoday.com/articles/234979.php)